Risk of pancreatic cancer associated with use of incretin-based therapy and other glucose-lowering agents

a nationwide case-control study in Denmark

R. W. Thomsen, D. H. Christensen, J. Kahlert, S. T. Knudsen, L. Pedersen, H. Nørrelund, O. M. Dekkers, I. Douglas, G. Marchesini, L. Smeeth, N. Moller, H. Beck-Nielsen, J. O. Jørgensen, H. T. Sørensen

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalDiabetologia
Volume58
Issue numberS1
Pages (from-to)S8-S9
ISSN0012-186X
DOIs
Publication statusPublished - 2015
Event51st EASD Annual Meeting - Stockholm, Sweden
Duration: 14. Sep 201518. Sep 2015

Conference

Conference51st EASD Annual Meeting
CountrySweden
CityStockholm
Period14/09/201518/09/2015

Cite this

Thomsen, R. W., Christensen, D. H., Kahlert, J., Knudsen, S. T., Pedersen, L., Nørrelund, H., ... Sørensen, H. T. (2015). Risk of pancreatic cancer associated with use of incretin-based therapy and other glucose-lowering agents: a nationwide case-control study in Denmark. Diabetologia, 58(S1), S8-S9. https://doi.org/10.1007/s00125-015-3687-4
Thomsen, R. W. ; Christensen, D. H. ; Kahlert, J. ; Knudsen, S. T. ; Pedersen, L. ; Nørrelund, H. ; Dekkers, O. M. ; Douglas, I. ; Marchesini, G. ; Smeeth, L. ; Moller, N. ; Beck-Nielsen, H. ; Jørgensen, J. O. ; Sørensen, H. T. / Risk of pancreatic cancer associated with use of incretin-based therapy and other glucose-lowering agents : a nationwide case-control study in Denmark. In: Diabetologia. 2015 ; Vol. 58, No. S1. pp. S8-S9.
@article{885c1a3f4e314f83bdab411dff27d64a,
title = "Risk of pancreatic cancer associated with use of incretin-based therapy and other glucose-lowering agents: a nationwide case-control study in Denmark",
author = "Thomsen, {R. W.} and Christensen, {D. H.} and J. Kahlert and Knudsen, {S. T.} and L. Pedersen and H. N{\o}rrelund and Dekkers, {O. M.} and I. Douglas and G. Marchesini and L. Smeeth and N. Moller and H. Beck-Nielsen and J{\o}rgensen, {J. O.} and S{\o}rensen, {H. T.}",
note = "51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) SEP 14-18, 2015 Stockholm, SWEDEN European Assoc Study Diabet 0 1",
year = "2015",
doi = "10.1007/s00125-015-3687-4",
language = "English",
volume = "58",
pages = "S8--S9",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Heinemann",
number = "S1",

}

Thomsen, RW, Christensen, DH, Kahlert, J, Knudsen, ST, Pedersen, L, Nørrelund, H, Dekkers, OM, Douglas, I, Marchesini, G, Smeeth, L, Moller, N, Beck-Nielsen, H, Jørgensen, JO & Sørensen, HT 2015, 'Risk of pancreatic cancer associated with use of incretin-based therapy and other glucose-lowering agents: a nationwide case-control study in Denmark', Diabetologia, vol. 58, no. S1, pp. S8-S9. https://doi.org/10.1007/s00125-015-3687-4

Risk of pancreatic cancer associated with use of incretin-based therapy and other glucose-lowering agents : a nationwide case-control study in Denmark. / Thomsen, R. W.; Christensen, D. H.; Kahlert, J.; Knudsen, S. T.; Pedersen, L.; Nørrelund, H.; Dekkers, O. M.; Douglas, I.; Marchesini, G.; Smeeth, L.; Moller, N.; Beck-Nielsen, H.; Jørgensen, J. O.; Sørensen, H. T.

In: Diabetologia, Vol. 58, No. S1, 2015, p. S8-S9.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

TY - ABST

T1 - Risk of pancreatic cancer associated with use of incretin-based therapy and other glucose-lowering agents

T2 - a nationwide case-control study in Denmark

AU - Thomsen, R. W.

AU - Christensen, D. H.

AU - Kahlert, J.

AU - Knudsen, S. T.

AU - Pedersen, L.

AU - Nørrelund, H.

AU - Dekkers, O. M.

AU - Douglas, I.

AU - Marchesini, G.

AU - Smeeth, L.

AU - Moller, N.

AU - Beck-Nielsen, H.

AU - Jørgensen, J. O.

AU - Sørensen, H. T.

N1 - 51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) SEP 14-18, 2015 Stockholm, SWEDEN European Assoc Study Diabet 0 1

PY - 2015

Y1 - 2015

U2 - 10.1007/s00125-015-3687-4

DO - 10.1007/s00125-015-3687-4

M3 - Conference abstract in journal

VL - 58

SP - S8-S9

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - S1

ER -